EksoNR Robotic Exoskeleton

EksoNR™ Robotic Exoskeleton

As part of our commitment to rehabilitation, Holy Cross Health uses cutting-edge technology to help patients regain their strength, mobility, confidence, and freedom. EksoNR is the first robotic exoskeleton FDA cleared for stroke and spinal cord injury neurorehabilitation and the only exoskeleton FDA cleared for acquired brain injury and multiple sclerosis (MS). The wearable device augments strength to help these patients stand and relearn to walk, improving their step patterns, weight shifting, and posture. Holy Cross Health is using the device to mobilize patients earlier in their rehabilitation.

As of 2022, each year nearly 60M people experience an acquired brain injury, 15M experience a stroke, and as many as 500,000 individuals experience a spinal cord injury (SCI). There are also more than 1 million people living with MS in the US alone. Early mobilization is especially beneficial for stroke recovery. Gait training with this exoskeleton suit is one of the latest advancements in stroke treatment and neurorehabilitation in general.

Clinical research suggests that including EksoNR gait training during inpatient rehabilitation can improve patients’ gait speed and walking distance. It is the most clinically used exoskeleton and patients around the world have taken over 200 million steps and counting.

*reference Ekso Bionics website for updated figures and for Clinical Summary

For more information on rehabilitation for stroke, brain injury, spinal cord injury, or MS using EksoNR robotic exoskeleton, call 954-351-5942 or 954-351-5958. A physical therapy evaluation will help determine eligibility to use the exoskeleton in rehabilitation.

Ekso Patient and PT